Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines...

|About: Vical Incorporated (VICL)|By:, SA News Editor

Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines "substantially increases both antibody and T-cell responses." VICL's VP of vaccine research says seasonal influenza vaccines sometimes underperform in elderly patients — "a good adjuvant could" help, he adds. (PR)